Tirbanibulin
id:
tirbanibulin-219-700997
title:
Tirbanibulin
text:
Tirbanibulin, sold under the brand name Klisyri, is a medication used for the treatment of actinic keratosis (AK) on the face or scalp. It functions by inhibiting both tubulin polymerization and Src kinase signaling. It is potentially effective in impeding the development of squamous cell carcinoma in situ. The most common side effects include local skin reactions, application site pruritus, and application site pain. Tirbanibulin was approved for medical use in the United States in December 202
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Tirbanibulin
date created:
2020-12-16T07:43:03Z
date modified:
2024-09-13T15:16:31Z
main entity:
{"identifier":"Q27888424","url":"https://www.wikidata.org/entity/Q27888424"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d2/Tirbanibulin.svg","width":512,"height":181}
fields total:
13
integrity:
16